Current data has a 15-minute delay. Please Sign Up /
Sign In to get real-time quotes.
stocks
/
NASDAQ-IKT
/
I
Inhibikase
IKT
IKTInhibikaseNASDAQ
Add to watchlist
118.66
0.31(+0.26 %)
At close :
--
Pre market
07:34 ET
I
Inhibikase
IKT
(IKT)
118.66
0.31(+0.26 %)
Summary
Options
Financials
News
Filings
Profile
IKT Chart
See on advanced chart >
...
All
...
D
...
W
...
M
...
5m
...
Volume--
Turnover--
P/E(TTM)--
Turnover %--%
P/E(Static)--
Market Cap--
P/B--
Shares--
52 Week Range
--
--
Day Range
--
--
About
Inhibikase Therapeutics, Inc., incorporated on June 3, 2010 as a Delaware corporation. The company is a clinical stage pharmaceutical company developing therapeutics for Parkinson's Disease, or PD, and related disorders that arise inside and outside of the...
Read More
Highlight
A clinical stage pharmaceutical company that develops therapeutics for Parkinson’s Disease and related brain disorders